Advantages of the Spatz3 Adjustable Intragastric Balloon over Ordinary Intragastric Balloons

Higher Success Rate

The average weight loss result of a particular intragastric balloon is important – but it does not tell the whole story. It tells you the average result of the entire group of patients – but it doesn’t tell you what your chances of success are.
Published studies with the Spatz3 Adjustable balloon report success rates of 71.5%-88.5% 1,2,3,4. In other standard non-adjustable balloons the published success rates are 45.6%-48%5,6,7.

Why are success rates higher with the Spatz3 Adjustable Balloon?

Adjustability: Published studies report 14%-22% of non-adjustable balloons are removed early due to intolerance. Those patients do not succeed. Spatz3 patients can reduce balloon volume when needed and those patients are saved from early removal. Those patients succeed.

Enhanced Balloon Effect: Published studies report that balloon effect diminishes on average after the first 3 months, and patients can start to regain weight at the 4th-5th month with non-adjustable balloons. Those patients do not succeed. Spatz3 patients can have balloon volume increased when needed and those patients are prevented from gaining weight. Those patients succeed.

Longer Implantation Time: The balloon will help you change your eating habits, however, six months is not enough time to internalize those changes.Spatz developed a high quality balloon that can remain in the stomach for 1 year – better weight loss results

Approved for one year implantation – twice as long as other gastric balloons!

Due to the risk of complications, other gastric balloons are restricted to 6 months of use. The Spatz3 balloon is a unique, high-quality injection molded balloon. In our studies, the Spatz3 has been proven safe enough to remain in the stomach for 12 full months. This success allowed the regulatory authorities to approve an extension of implantation of the Spatz3 balloon from 6 months to one year.

Adjustability – because keeping a balloon for longer than 6 months will not help unless you change the balloon volume.

As the name implies, the Spatz3 gastric balloon is adjustable in size – even once it’s been placed inside your stomach. After the first months of successful weight loss, your body acclimatizes to the balloon and standard intragastric balloons begin to lose their effectiveness. In fact, studies have shown that, with today’s gastric balloons, 80% of the weight loss occurs in the first three months.

Simply leaving the gastric balloon in longer does not increase weight loss significantly. Physicians have told us that they would like to be able to add volume to the balloon – to “top it off”, encouraging similar levels of weight loss in the coming months. The unique Spatz3 Adjustable Balloon System allows the physician to perform a simple 15-minute outpatient procedure to add fluid to the balloon at any time. Each volume addition produces a fresh effect, facilitating renewed weight loss and increasing your chances for weight loss success. In addition there are published studies that report weight maintenance even 2 years after Spatz balloon removal8

Our clinical trials have reported an additional 5-10 kg weight loss following volume adjustments.1-4, 9-12  

It is important to be aware that the first few days with an intragastric balloon can be uncomfortable. You’ll need to overcome unpleasantness and nausea while your body adjusts to the balloon. In a small number of cases, despite real determination, some patients are just unable to manage. Instead of abandoning the patient’s investment in their weight loss program, the physician can perform a simple endoscopy to remove some fluid from the balloon. This adjustment allows the treatment to continue. Our studies have reported improved tolerance of the balloon, yet weight loss continues after a reduction of the balloon volume. Later, when the patient’s body has acclimated, another endoscopy procedure can be performed to increase the gastric balloon volume.

Adjustability is just one of the features that make the Spatz3 Adjustable Balloon System a clear standout in the growing field of non-surgical weight loss therapies.

Easier to Use

The easier a product is for the physician to use, the safer it is for the patient. The Spatz3 Adjustable Balloon System has a unique insertion facilitator to ease the insertion procedure for physicians, resulting in a safer procedure for you.

    1. Machytka, Evzen; Puig Divi, Valenti; Saenger, Fernando; Sorio, Ricardo; Brooks, Jeffrey. Adjustable Balloons for Weight Loss: A Higher Yield of Responders Compared with Non-Adjustable Balloons. DDW 2017 Abstract.
    2. Usuy Eduardo, Brooks Jeffrey. Response Rates with the Spatz3 Adjustable Balloon. Obes Surg. 2017 Oct 31. doi: 10.1007/s11695-017-2994-x. [Epub ahead of print]
    3. Almeida Leonardo S. Spatz3 Adjustable Balloon; Weight Loss And Response Rates In Brazil. DDW 2018 Abstract
    4. Brooks J. Adjustable Intragastric Balloons Improve Response Rates. DDW 2018 Abstract
    5. FDA SSED Reshape Duo Balloon. PMA P140012: FDA summary of safety and effectiveness data. July 28, 2015.
    6. FDA SSED Orbera Balloon. PMA P140008: FDA summary of safety and effectiveness data. August 5, 2015.
    7. Courcoulas A et al. Intragastric balloon as an adjunct to lifestyle intervention:a randomized controlled trial. Int J Obes. 2017;41:427–33.
    1. Machytka E, Mason J, Puig V, Lopez Nava G. Weight Maintenance 2 Years after Spatz Adjustable Balloo Extraction. UEGW 2014 Poster
    2. Machytka E, Kowalczyk Z,….Brooks J. First reports of the new Spatz 3 adjustable balloon system. UEG14ABS-1296
    3. Lopez-Nava G, Gostout C, Nebreda J, Brooks J. A new adjustable intragastric balloon: the first patient experience in Spain. UEGW11-5345
    4. Machytka E1, Marinos G2, Kerdahi R3, Srivastava ED4, AlLehibi A5 ,Mason J6, Brooks J7. Spatz Adjustable Balloons: Results of Adjustment for Intolerance and for Weight Loss Plateau. DDW 2015, IFSO 2015
    5. Brooks J, Tsvang E, Ganon M, Arnon R. Spatz3 Adjustable Balloon:Early adjustment to prevent premature extraction.DDW 2016